These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 31958402)

  • 1. Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study.
    DeVito NJ; Bacon S; Goldacre B
    Lancet; 2020 Feb; 395(10221):361-369. PubMed ID: 31958402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012.
    Miller JE; Korn D; Ross JS
    BMJ Open; 2015 Nov; 5(11):e009758. PubMed ID: 26563214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compliance with results reporting at ClinicalTrials.gov.
    Anderson ML; Chiswell K; Peterson ED; Tasneem A; Topping J; Califf RM
    N Engl J Med; 2015 Mar; 372(11):1031-9. PubMed ID: 25760355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trial transparency: a reassessment of industry compliance with clinical trial registration and reporting requirements in the United States.
    Lassman SM; Shopshear OM; Jazic I; Ulrich J; Francer J
    BMJ Open; 2017 Sep; 7(9):e015110. PubMed ID: 28942418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trial reporting performance of thirty UK universities on ClinicalTrials.gov-evaluation of a new tracking tool for the US clinical trial registry.
    Keestra SM; Rodgers F; Lenz D; Osborne R; Bruckner T; Lee S
    Trials; 2021 Jun; 22(1):375. PubMed ID: 34074329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional study.
    Prayle AP; Hurley MN; Smyth AR
    BMJ; 2012 Jan; 344():d7373. PubMed ID: 22214756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compliance on Mandatory Data Reporting in Registered Obstetrics Trials.
    Checketts JX; Evans MB; Athale AH; Jawhar OM; Wright MR; Bryant K; Vassar M
    Am J Perinatol; 2018 Oct; 35(12):1192-1196. PubMed ID: 29695018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trial registration and results disclosure: impact of US legislation on sponsors, investigators, and medical journal editors.
    Hirsch L
    Curr Med Res Opin; 2008 Jun; 24(6):1683-9. PubMed ID: 18462565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies.
    Miller JE; Wilenzick M; Ritcey N; Ross JS; Mello MM
    BMJ Open; 2017 Dec; 7(12):e017917. PubMed ID: 29208616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Registration, results reporting, and publication bias of clinical trials supporting FDA approval of neuropsychiatric drugs before and after FDAAA: a retrospective cohort study.
    Zou CX; Becker JE; Phillips AT; Garritano JM; Krumholz HM; Miller JE; Ross JS
    Trials; 2018 Oct; 19(1):581. PubMed ID: 30352601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research without results: inadequate public reporting of clinical trial results.
    Gopal RK; Yamashita TE; Prochazka AV
    Contemp Clin Trials; 2012 May; 33(3):486-91. PubMed ID: 22342449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sponsors' and investigative staffs' perceptions of the current investigational new drug safety reporting process in oncology trials.
    Perez R; Archdeacon P; Roach N; Goodwin R; Jarow J; Stuccio N; Forrest A
    Clin Trials; 2017 Jun; 14(3):225-233. PubMed ID: 28345368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming non-compliance with clinical trial registration and results reporting: One Institution's approach.
    Snider SH; Flume PA; Gentilin SL; Lesch WA; Sampson RR; Sonne SC
    Contemp Clin Trials Commun; 2020 Jun; 18():100557. PubMed ID: 32258818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consistency of trial reporting between ClinicalTrials.gov and corresponding publications: one decade after FDAAA.
    Talebi R; Redberg RF; Ross JS
    Trials; 2020 Jul; 21(1):675. PubMed ID: 32703252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the FDA Amendment Act with trial registration, publication, and outcome reporting.
    Phillips AT; Desai NR; Krumholz HM; Zou CX; Miller JE; Ross JS
    Trials; 2017 Jul; 18(1):333. PubMed ID: 28720112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reporting Compliance and Factors Influencing Timeliness of Stroke-Related Trial Results on ClinicalTrials.gov.
    Cwajna M; Hamouda AM; Kendall N; Ghozy S; Elder BD; Kallmes DF
    Transl Stroke Res; 2024 Jun; ():. PubMed ID: 38831158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with reporting results for pulmonary clinical trials in ClinicalTrials.gov.
    Riley IL; Boulware LE; Sun JL; Chiswell K; Que LG; Kraft M; Todd JL; Palmer SM; Anderson ML
    Clin Trials; 2018 Feb; 15(1):87-94. PubMed ID: 29121787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Registration, publication, and outcome reporting among pivotal clinical trials that supported FDA approval of high-risk cardiovascular devices before and after FDAAA.
    Swanson MJ; Johnston JL; Ross JS
    Trials; 2021 Nov; 22(1):817. PubMed ID: 34789308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E-cigarette manufacturers' compliance with clinical trial reporting expectations: a case series of registered trials by Juul Labs.
    DeVito NJ; Drysdale H; McKee M; Goldacre B
    Tob Control; 2023 Jan; 32(1):60-66. PubMed ID: 34127550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDAAA legislation is working, but methodological flaws undermine the reliability of clinical trials: a cross-sectional study.
    Marin Dos Santos DH; Atallah ÁN
    PeerJ; 2015; 3():e1015. PubMed ID: 26131374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.